EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04465500
Phase: Phase 2
Trial Summary: This study is trying to find out if the combination of Androgen deprivation therapy (ADT), MRI guided high dose radiation (HDR) brachytherapy treatment (internal radiation implant – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Virginia
Acronym
: Prostate005

Pin It on Pinterest